FSANZ approves five human milk oligosaccharides from E. coli BL21 for use in infant formula

What this variation does

Food Standards Australia New Zealand (FSANZ) has approved a variation to the Food Standards Code under Application A1339. The variation permits five specific human milk oligosaccharides - 2'-FL, 3-FL, LNT, 3'-SL and 6'-SL - produced from the bacterial strain Escherichia coli BL21 to be used as nutritive substances in infant formula products.

Effective date

This rule came into force on 28 August 2026.

Enabling legislation and administration

The variation is administered by the Department of Health, Disability and Ageing under the Food Standards Australia New Zealand Act 1991.

Where to find the full instrument

The source page provides only registration and status details. It does not specify transition periods, labelling requirements, or conditions of use beyond what is contained in the full legislative instrument and explanatory statement. Both documents are available at the Federal Register of Legislation: https://www.legislation.gov.au/F2026L01127

For further information, FSANZ can be contacted through its website: https://www.foodstandards.gov.au

This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.